Get started
Author

Yoshiko Yokota

Observed names: Y Yokota, YOSHIKO YOKOTA, Yokota Yoshiko, Yoshiko YOKOTA, 好子 横田
OpenAlex ID: A5111688161
Clonal Association ofStaphylococcus aureusCausing Bullous Impetigo and the Emergence of New Methicillin‐Resistant Clonal Groups in Kansai District in Japan
2002 · Takayuki Yamaguchi, Yoshiko Yokota, et al. · The Journal of Infectious Diseases · 89
Immunoactive peptides, FK-156 and FK-565. I. Enhancement of host resistance to microbial infection in mice.
1983 · YASUHIRO MINE, YOSHIKO YOKOTA, et al. · The Journal of Antibiotics · 66
PDF
Cefazolin, a New Semisynthetic Cephalosporin Antibiotic. Ii
1970 · MINORU NISHIDA, TADAO MATSUBARA, et al. · The Journal of Antibiotics · 55
PDF
The Association ofHelicobacter pylori with Differentiated-Type Early Gastric Cancer
1993 · Masaharu Tatsuta, Hiroyasu Iishi, et al. · Cancer · 54
PDF
Tissue Distribution after Intravenous Dosing of Micafungin, an Antifungal Drug, to Rats
2004 · Toshiro Niwa, Yoshiko Yokota, et al. · Biological and Pharmaceutical Bulletin · 53
PDF
Bismuth(III) Complexes of 2-Mercaptoethanol: Preparation, Structural and Spectroscopic Characterization, Antibactericidal Activity toward Helicobacter pylori, and Inhibitory Effect toward H. pylory-Produced Urease
1997 · Eiji Asato, Koji Kamamuta, et al. · Bulletin of the Chemical Society of Japan · 52
Cefazolin, a New Semisynthetic Cephalosporin Antibiotic. Iii
1970 · MINORU NISHIDA, TADAO MATSUBARA, et al. · The Journal of Antibiotics · 52
PDF
A biodegradable delivery system for antibiotics and recombinant human bone morphogenetic protein‐2: A potential treatment for infected bone defects
2006 · Akinobu Suzuki, Hidetomi Terai, et al. · Journal of Orthopaedic Research® · 47
PDF
Immunoactive Peptides, Fk-156 and Fk-565. Iii
1983 · YASUHIRO MINE, YUJI WATANABE, et al. · The Journal of Antibiotics · 42
PDF
Ganciclovir for chronic active Epstein-Barr virus infection
1993 · Yasushi Ishida, Yoshiko Yokota, et al. · The Lancet · 39
Low Prevalence of Helicobacter pylori Infection in Patients with Hamartomatous Fundic Polyps
1998 · Noriko Sakai, Masaharu Tatsuta, et al. · Digestive Diseases and Sciences · 37
Isolation of soil strains producing new cephalosporin acylases
1991 · Ichiro Aramori, Masao Fukagawa, et al. · Journal of Fermentation and Bioengineering · 36
Effect of Antibiotics on the Phagocytosis and Killing of Pseudomonas aeruginosa by Rabbit Polymorphonuclear Leukocytes
2009 · Minoru Nishida, Yasuhiro Mine, et al. · Chemotherapy · 33
In Vitro and In Vivo Evaluation of Ceftezole, a New Cephalosporin Derivative
1976 · Minoru Nishida, Takeo Murakawa, et al. · Antimicrobial Agents and Chemotherapy · 29
Immunoactive peptides, FK-156 and FK-565. II. Restoration of host resistance to microbial infection in immunosuppressed mice.
1983 · YOSHIKO YOKOTA, YASUHIRO MINE, et al. · The Journal of Antibiotics · 23
PDF
Laboratory evaluation of FR10612, a new oral cephalosporin derivative.
1976 · MINORU NISHIDA, TAKEO MURAKAWA, et al. · The Journal of Antibiotics · 23
PDF
Characterization of BRO Enzymes and Beta-Lactamase Transfer of Moraxella (Branhamella)catatrhalis Isolated in Japan
2009 · Fumiaki lkeda, Yoshiko Yokota, et al. · Chemotherapy · 16
Studies on Microbial Degradation of Cephalosporin C Derivatives. I
1968 · MINORU NISHIDA, YOSHIKO YOKOTA, et al. · The Journal of Antibiotics · 12
PDF
Capnocytophaga sputigena Bacteremia Associated with Acute Leukemia
1993 · Hisashi FUNADA, Toshihiko MACHI, et al. · Kansenshogaku zasshi · 10
PDF
Inhibitory effect of FK-565 alone and in combination with zidovudine on retroviral infection by Friend leukemia virus in mice.
1988 · YOSHIKO YOKOTA, YOSHIMI WAKAI, et al. · The Journal of Antibiotics · 10
PDF
In vitro synergism of FR-31564, a new phosphonic acid antibiotic.
1981 · YOSHIKO YOKOTA, TAKEO MURAKAWA, et al. · The Journal of Antibiotics · 10
PDF
Interaction of Beta-Lactam Antibiotics with the Penicillin-Binding Proteins of Penicillin-Resistant Streptococcus pneumoniae
2009 · Fumiaki Ikeda, Yoshiko Yokota, et al. · Chemotherapy · 9
Protective effects of immunoactive peptide, FK565 against systemic and local infections with herpes simplex virus and murine cytomegalovirus and respiratory tract infection with influenza virus in mice.
1992 · YOSHIKO YOKOTA, YUJI WATANABE, et al. · The Journal of Antibiotics · 8
PDF
In vivo antibacterial activity of FK482, a new orally active cephalosporin.
1988 · YASUHIRO MINE, YOSHIKO YOKOTA, et al. · The Journal of Antibiotics · 8
PDF
Characteristics of Biliary Excretion of Cefazolin and Other Cephalosporins with Reference to the Relationship between Serum Levels and Administration Conditions
2009 · Minoru Nishida, Takeo Murakawa, et al. · Chemotherapy · 5
Works count: 51
Citation count: 847
H-index: 16
I10-index: 21
Year
Topic
Type